Publications by authors named "A Lambiase"

Purpose: Osteogenesis imperfecta (OI) is a rare hereditary disorder of the connective tissue. Despite recent attention to corneal abnormalities in OI, understanding remains limited. This study aimed to comprehensively evaluate corneal changes in a large sample of OI patients compared to controls using in vivo confocal microscopy (IVCM).

View Article and Find Full Text PDF

Neurodegenerative diseases are among the major challenges in modern medicine, due to the progressive aging of the world population. Among these, Parkinson's disease (PD) affects 10 million people worldwide and is associated with the aggregation of the presynaptic protein α-synuclein (α-syn). Here we use two different PD models, yeast cells and neuroblastoma cells overexpressing α-syn, to investigate the protective effect of an extract from the cocoa shell, which is a by-product of the roasting process of cocoa beans.

View Article and Find Full Text PDF

Objectives: Our objective was to investigate the prevalence of macular complications detected by spectral-domain optical coherence tomography (SD-OCT) in a large Caucasian cohort of RP patients, highlight the major alterations in chorioretinal structure, and compare the macular structural changes in eyes affected by retinal dystrophies with those in healthy controls.

Methods: This was an observational, retrospective, and cross-sectional study. Three hundred and seven patients with RP were consecutively enrolled and underwent clinical assessment.

View Article and Find Full Text PDF
Article Synopsis
  • Proliferative vitreoretinopathy (PVR) causes fibrotic membranes that lead to recurrent retinal detachment, with current treatment (pars plana vitrectomy) having high recurrence rates due to unresolved underlying issues.
  • There are no approved pharmacological therapies for PVR, largely because of ethical and safety concerns in preclinical and in vivo studies.
  • The review discusses the potential of computational models and Digital Twins in developing personalized treatment strategies, highlighting nintedanib as a promising drug candidate for simulating effects on fibrotic pathways.
View Article and Find Full Text PDF